Discover why Hims & Hers Health (HIMS) remains a strong long-term buy after robust Q3 growth, new offerings, and expansion ...
AI is changing the market rapidly. Here are handful of top fourth-quarter recommendations from top strategists.
"I wish a doctor had mentioned this as a possible side effect. I thought I had asked the correct questions and was on one of ...
Milei cuts government, slashes departments, and fires 5,000 workers.US bailout fuels libertarian experiment amid economic reform in Argentina.Liberta ...
A groundbreaking new tool created by an international team of scientists could help doctors spot people at higher risk for ...
MaxCyte will now host its earnings conference call on November 12, 2025 Management will present at the Stifel Healthcare Conference on November 11, 2025 and Stephens Investment Conference on November ...
AI-generated personalized bipolar management plans present growth opportunities driven by rising mental health awareness, demand for personalized care, and AI advancements. Key trends include digital ...
The dairy business and industry in Oman grapples with complex challenges, from wavering milk prices and escalating input ...
Investor's Business Daily on MSN
Sarepta Loses A Third Of Its Value On Failed Tests, Gene Therapy Outlook
Sarepta stock crashed Tuesday after the biotech company said two of its muscular dystrophy drugs failed confirmatory tests.
According to Nova One Advisor, the global exosome research market size is calculated at USD 225.72 million in 2025 and is ...
Q3 2025 Earnings Call October 30, 2025 9:00 AM EDTCompany ParticipantsAlison Johnson - Director of Investor RelationsKeelan Adamson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback